A new drug-eluting stent that does not live up to its promise

Research output: Contribution to journalArticle

2 Scopus citations


Drug-eluting stents are an established treatment option for coronary artery disease, although they are not without their problems. The MAHOROBA® stent attempts to harness the theoretical advantages of both tacrolimus and polymer degradation, but has proved not to be effective in the treatment of de novo coronary lesions.

Original languageEnglish (US)
Pages (from-to)500-501
Number of pages2
JournalNature Reviews Cardiology
Issue number8
StatePublished - Aug 2009


ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this